Skip to content

US researchers estimate HIV treatment will work for 24 years and cost £200k

Genetically modified HIV shows early promise as a gene therapy viral vector

Fear of increased appetite proves obstacle to adherence in Rwanda

Radioimmunotherapy clears HIV-infected cells in mice

Brazil begins negotiations over Kaletra price again

Antenatal cotrimoxazole prophylaxis leads to cost-effective reduction in preterm delivery and neonatal mortality, Zambian study reveals

Second generic abacavir approved for PEPFAR

New risk factors for severe liver toxicity identified in largest ever clinical trial-based analysis

Extensively drug-resistant TB (XDR-TB) present throughout the world